Compare HF Sinclair Corporation Common Stock (DINO) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HF Sinclair Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? HF Sinclair Corporation Common Stock trades at $120.86 (market cap $21.46B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: HF Sinclair Corporation Common Stock is the larger of the two by market cap, and HF Sinclair Corporation Common Stock pays a 1.74% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HF Sinclair Corporation Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| DINO | HALO | |
|---|---|---|
Market Cap | $21.46B | $12.58B |
Volume | 2,430,580 | 2,179,278 |
Sector | Energy | Health |
52-Week High | $120.72 | $115.22 |
52-Week Low | $45.88 | $61.63 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $22.44B | $14.49B |
Dividend Yield | 1.74% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HF Sinclair Corporation Common Stock
HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.
Read more on DINO →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
